{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T19:01:56Z","timestamp":1794423716277,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1742-4690-10-161","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T22:58:31Z","timestamp":1387839511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells"],"prefix":"10.1186","volume":"10","author":[{"given":"Boghuma Kabisen","family":"Titanji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlen","family":"Aasa-Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deenan","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,24]]},"reference":[{"issue":"6","key":"3645_CR1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/bies.201200170","volume":"35","author":"L Shan","year":"2013","unstructured":"Shan L, Siliciano RF: From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication. Bioessays. 2013, 35 (6): 544-552. 10.1002\/bies.201200170.","journal-title":"Bioessays"},{"issue":"4","key":"3645_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nm.2111","volume":"16","author":"MJ Buzon","year":"2010","unstructured":"Buzon MJ, Massanella M, Llibre JM, Esteve A, Dahl V, Puertas MC, Gatell JM, Domingo P, Paredes R, Sharkey M, et al: HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med. 2010, 16 (4): 460-465. 10.1038\/nm.2111.","journal-title":"Nat Med"},{"issue":"15","key":"3645_CR3","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1097\/QAD.0b013e3283584521","volume":"26","author":"A Vallejo","year":"2012","unstructured":"Vallejo A, Gutierrez C, Hernandez-Novoa B, Diaz L, Madrid N, Abad-Fernandez M, Dronda F, Perez-Elias MJ, Zamora J, Munoz E, et al: The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients. AIDS. 2012, 26 (15): 1885-1894. 10.1097\/QAD.0b013e3283584521.","journal-title":"AIDS"},{"issue":"16","key":"3645_CR4","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1097\/QAD.0b013e32833ef7bb","volume":"24","author":"SA Yukl","year":"2010","unstructured":"Yukl SA, Shergill AK, McQuaid K, Gianella S, Lampiris H, Hare CB, Pandori M, Sinclair E, Gunthard HF, Fischer M, et al: Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2010, 24 (16): 2451-2460. 10.1097\/QAD.0b013e32833ef7bb.","journal-title":"AIDS"},{"issue":"10","key":"3645_CR5","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1128\/JVI.77.10.5721-5730.2003","volume":"77","author":"LM Frenkel","year":"2003","unstructured":"Frenkel LM, Wang Y, Learn GH, McKernan JL, Ellis GM, Mohan KM, Holte SE, De Vange SM, Pawluk DM, Melvin AJ, et al: Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. J Virol. 2003, 77 (10): 5721-5730. 10.1128\/JVI.77.10.5721-5730.2003.","journal-title":"J Virol"},{"issue":"8","key":"3645_CR6","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1086\/382488","volume":"189","author":"TL Kieffer","year":"2004","unstructured":"Kieffer TL, Finucane MM, Nettles RE, Quinn TC, Broman KW, Ray SC, Persaud D, Siliciano RF: Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. J Infect Dis. 2004, 189 (8): 1452-1465. 10.1086\/382488.","journal-title":"J Infect Dis"},{"issue":"13","key":"3645_CR7","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1128\/JVI.00591-06","volume":"80","author":"JR Bailey","year":"2006","unstructured":"Bailey JR, Sedaghat AR, Kieffer T, Brennan T, Lee PK, Wind-Rotolo M, Haggerty CM, Kamireddi AR, Liu Y, Lee J, et al: Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol. 2006, 80 (13): 6441-6457. 10.1128\/JVI.00591-06.","journal-title":"J Virol"},{"issue":"5922","key":"3645_CR8","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1126\/science.1167525","volume":"323","author":"W Hubner","year":"2009","unstructured":"Hubner W, McNerney GP, Chen P, Dale BM, Gordon RE, Chuang FY, Li XD, Asmuth DM, Huser T, Chen BK: Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science. 2009, 323 (5922): 1743-1747. 10.1126\/science.1167525.","journal-title":"Science"},{"issue":"9","key":"3645_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1600-0854.2004.00209.x","volume":"5","author":"C Jolly","year":"2004","unstructured":"Jolly C, Sattentau QJ: Retroviral spread by induction of virological synapses. Traffic. 2004, 5 (9): 643-650. 10.1111\/j.1600-0854.2004.00209.x.","journal-title":"Traffic"},{"issue":"11","key":"3645_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nrmicro1972","volume":"6","author":"Q Sattentau","year":"2008","unstructured":"Sattentau Q: Avoiding the void: cell-to-cell spread of human viruses. Nature Rev Microbiol. 2008, 6 (11): 815-826. 10.1038\/nrmicro1972.","journal-title":"Nature Rev Microbiol"},{"issue":"4","key":"3645_CR11","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1128\/jvi.67.4.2182-2190.1993","volume":"67","author":"DS Dimitrov","year":"1993","unstructured":"Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA: Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol. 1993, 67 (4): 2182-2190.","journal-title":"J Virol"},{"issue":"1","key":"3645_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.76.1.1-8.2002","volume":"76","author":"DC Johnson","year":"2002","unstructured":"Johnson DC, Huber MT: Directed egress of animal viruses promotes cell-to-cell spread. J Virol. 2002, 76 (1): 1-8. 10.1128\/JVI.76.1.1-8.2002.","journal-title":"J Virol"},{"issue":"2","key":"3645_CR13","doi-asserted-by":"publisher","first-page":"e1000788","DOI":"10.1371\/journal.ppat.1000788","volume":"6","author":"D Mazurov","year":"2010","unstructured":"Mazurov D, Ilinskaya A, Heidecker G, Lloyd P, Derse D: Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Path. 2010, 6 (2): e1000788-10.1371\/journal.ppat.1000788.","journal-title":"PLoS Path"},{"issue":"6","key":"3645_CR14","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/v2061306","volume":"2","author":"QJ Sattentau","year":"2010","unstructured":"Sattentau QJ: Cell-to-cell spread of retroviruses. Viruses. 2010, 2 (6): 1306-1321. 10.3390\/v2061306.","journal-title":"Viruses"},{"issue":"2","key":"3645_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/COH.0b013e328322f94a","volume":"4","author":"N Martin","year":"2009","unstructured":"Martin N, Sattentau Q: Cell-to-cell HIV-1 spread and its implications for immune evasion. Curr Opin HIV AIDS. 2009, 4 (2): 143-149. 10.1097\/COH.0b013e328322f94a.","journal-title":"Curr Opin HIV AIDS"},{"issue":"4","key":"3645_CR16","doi-asserted-by":"publisher","first-page":"e1002634","DOI":"10.1371\/journal.ppat.1002634","volume":"8","author":"IA Abela","year":"2012","unstructured":"Abela IA, Berlinger L, Schanz M, Reynell L, Gunthard HF, Rusert P, Trkola A: Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies. PLoS Path. 2012, 8 (4): e1002634-10.1371\/journal.ppat.1002634.","journal-title":"PLoS Path"},{"issue":"2","key":"3645_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1128\/JVI.01629-06","volume":"81","author":"M Sourisseau","year":"2007","unstructured":"Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O: Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol. 2007, 81 (2): 1000-1012. 10.1128\/JVI.01629-06.","journal-title":"J Virol"},{"key":"3645_CR18","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/ncomms2338","volume":"3","author":"X Sewald","year":"2012","unstructured":"Sewald X, Gonzalez DG, Haberman AM, Mothes W: In vivo imaging of virological synapses. Nat Comm. 2012, 3: 1320-","journal-title":"Nat Comm"},{"issue":"7419","key":"3645_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nature11398","volume":"490","author":"TT Murooka","year":"2012","unstructured":"Murooka TT, Deruaz M, Marangoni F, Vrbanac VD, Seung E, von Andrian UH, Tager AM, Luster AD, Mempel TR: HIV-infected T cells are migratory vehicles for viral dissemination. Nature. 2012, 490 (7419): 283-287. 10.1038\/nature11398.","journal-title":"Nature"},{"issue":"7362","key":"3645_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature10347","volume":"477","author":"A Sigal","year":"2011","unstructured":"Sigal A, Kim JT, Balazs AB, Dekel E, Mayo A, Milo R, Baltimore D: Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature. 2011, 477 (7362): 95-98. 10.1038\/nature10347.","journal-title":"Nature"},{"issue":"2","key":"3645_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.virol.2010.12.031","volume":"411","author":"C Jolly","year":"2011","unstructured":"Jolly C: Cell-to-cell transmission of retroviruses: innate immunity and interferon-induced restriction factors. Virology. 2011, 411 (2): 251-259. 10.1016\/j.virol.2010.12.031.","journal-title":"Virology"},{"issue":"22","key":"3645_CR22","doi-asserted-by":"publisher","first-page":"11117","DOI":"10.1128\/JVI.01046-08","volume":"82","author":"MW Richardson","year":"2008","unstructured":"Richardson MW, Carroll RG, Stremlau M, Korokhov N, Humeau LM, Silvestri G, Sodroski J, Riley JL: Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J Virol. 2008, 82 (22): 11117-11128. 10.1128\/JVI.01046-08.","journal-title":"J Virol"},{"issue":"16","key":"3645_CR23","doi-asserted-by":"publisher","first-page":"8773","DOI":"10.1128\/JVI.01044-12","volume":"86","author":"M Permanyer","year":"2012","unstructured":"Permanyer M, Ballana E, Ruiz A, Badia R, Riveira-Munoz E, Gonzalo E, Clotet B, Este JA: Antiretroviral agents effectively block HIV replication after cell-to-cell transfer. J Virol. 2012, 86 (16): 8773-8780. 10.1128\/JVI.01044-12.","journal-title":"J Virol"},{"issue":"3","key":"3645_CR24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.41.3.654","volume":"41","author":"DJ Kempf","year":"1997","unstructured":"Kempf DJ, Marsh KC, Kumar G, Rodrigues AD, Denissen JF, McDonald E, Kukulka MJ, Hsu A, Granneman GR, Baroldi PA, et al: Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. J Antimicrob Chemother. 1997, 41 (3): 654-660.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"3645_CR25","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1128\/AAC.49.6.2314-2321.2005","volume":"49","author":"S De Meyer","year":"2005","unstructured":"De Meyer S, Azijn H, Surleraux D, Jochmans D, Tahri A, Pauwels R, Wigerinck P, de Bethune MP: TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates. J Antimicrob Chemother. 2005, 49 (6): 2314-2321.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3645_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/QAD.0b013e32831c54e5","volume":"23","author":"WF Bierman","year":"2009","unstructured":"Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA: HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review. AIDS. 2009, 23 (3): 279-291. 10.1097\/QAD.0b013e32831c54e5.","journal-title":"AIDS"},{"issue":"1","key":"3645_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/QCO.0b013e3283422cdf","volume":"24","author":"I Perez-Valero","year":"2011","unstructured":"Perez-Valero I, Arribas JR: Protease inhibitor monotherapy. Curr Opinion Infect Dis. 2011, 24 (1): 7-11. 10.1097\/QCO.0b013e3283422cdf.","journal-title":"Curr Opinion Infect Dis"},{"issue":"9849","key":"3645_CR28","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","volume":"380","author":"RK Gupta","year":"2012","unstructured":"Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, Gregson J, Sawyer AW, Hamers RL, Ndembi N, Pillay D, et al: Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet. 2012, 380 (9849): 1250-1258. 10.1016\/S0140-6736(12)61038-1.","journal-title":"Lancet"},{"key":"3645_CR29","volume-title":"HIV Drug Resistance Report","author":"WHO","year":"2012","unstructured":"WHO: HIV Drug Resistance Report. 2012, Geneva, Switzerland: WHO HIV\/AIDS Prog, July 2012, http:\/\/www.who.int\/hiv\/pub\/drugresistance\/report2012\/en\/ accessed November 2013."},{"issue":"9","key":"3645_CR30","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1172\/JCI67399","volume":"123","author":"SA Rabi","year":"2013","unstructured":"Rabi SA, Laird GM, Durand CM, Laskey S, Shan L, Bailey JR, Chioma S, Moore RD, Siliciano RF: Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance. J Clin Inv. 2013, 123 (9): 3848-3860. 10.1172\/JCI67399.","journal-title":"J Clin Inv"},{"issue":"23","key":"3645_CR31","doi-asserted-by":"publisher","first-page":"12185","DOI":"10.1128\/JVI.01447-10","volume":"84","author":"C Jolly","year":"2010","unstructured":"Jolly C, Booth NJ, Neil SJ: Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin\/BST-2-mediated restriction in T cells. J Virol. 2010, 84 (23): 12185-12199. 10.1128\/JVI.01447-10.","journal-title":"J Virol"},{"issue":"11","key":"3645_CR32","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1128\/JVI.01469-06","volume":"81","author":"C Jolly","year":"2007","unstructured":"Jolly C, Mitar I, Sattentau QJ: Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J Virol. 2007, 81 (11): 5547-5560. 10.1128\/JVI.01469-06.","journal-title":"J Virol"},{"issue":"7","key":"3645_CR33","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1128\/JVI.02651-09","volume":"84","author":"N Martin","year":"2010","unstructured":"Martin N, Welsch S, Jolly C, Briggs JA, Vaux D, Sattentau QJ: Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. J Virol. 2010, 84 (7): 3516-3527. 10.1128\/JVI.02651-09.","journal-title":"J Virol"},{"issue":"6","key":"3645_CR34","doi-asserted-by":"publisher","first-page":"e1000955","DOI":"10.1371\/journal.ppat.1000955","volume":"6","author":"N Casartelli","year":"2010","unstructured":"Casartelli N, Sourisseau M, Feldmann J, Guivel-Benhassine F, Mallet A, Marcelin AG, Guatelli J, Schwartz O: Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Path. 2010, 6 (6): e1000955-10.1371\/journal.ppat.1000955.","journal-title":"PLoS Path"},{"issue":"1","key":"3645_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350801300101","volume":"13","author":"D Back","year":"2008","unstructured":"Back D, Sekar V, Hoetelmans RM: Darunavir: pharmacokinetics and drug interactions. Antivir Ther. 2008, 13 (1): 1-13.","journal-title":"Antivir Ther"},{"issue":"9","key":"3645_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2165\/00003088-200746090-00002","volume":"46","author":"M Rittweger","year":"2007","unstructured":"Rittweger M, Arasteh K: Clinical pharmacokinetics of darunavir. Clin Pharmacokinet. 2007, 46 (9): 739-756. 10.2165\/00003088-200746090-00002.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"3645_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1310\/WMWL-6W9Y-PXV2-X148","volume":"3","author":"A Lafeuillade","year":"2002","unstructured":"Lafeuillade A, Solas C, Halfon P, Chadapaud S, Hittinger G, Lacarelle B: Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations. HIV Clin Trials. 2002, 3 (1): 27-35. 10.1310\/WMWL-6W9Y-PXV2-X148.","journal-title":"HIV Clin Trials"},{"key":"3645_CR38","volume-title":"Meth Mol Biol: HIV Protocols. Volume","author":"Kalpana VRPaGV","year":"2008","unstructured":"Kalpana VRPaGV: Analysis of 2LTR junctions of viral DNA in infected cells. Meth Mol Biol: HIV Protocols. Volume. Edited by: Springerlink. 2008, New York, USA: Humana Press, Second","edition":"Second"},{"issue":"14","key":"3645_CR39","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1128\/JVI.00230-12","volume":"86","author":"ND Durham","year":"2012","unstructured":"Durham ND, Yewdall AW, Chen P, Lee R, Zony C, Robinson JE, Chen BK: Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail. J Virol. 2012, 86 (14): 7484-7495. 10.1128\/JVI.00230-12.","journal-title":"J Virol"},{"issue":"2","key":"3645_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/QAD.0b013e32831ef1a3","volume":"23","author":"M Massanella","year":"2009","unstructured":"Massanella M, Puigdomenech I, Cabrera C, Fernandez-Figueras MT, Aucher A, Gaibelet G, Hudrisier D, Garcia E, Bofill M, Clotet B, et al: Anti gp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells. AIDS. 2009, 23 (2): 183-188. 10.1097\/QAD.0b013e32831ef1a3.","journal-title":"AIDS"},{"issue":"22","key":"3645_CR41","doi-asserted-by":"publisher","first-page":"12582","DOI":"10.1128\/JVI.00381-07","volume":"81","author":"P Chen","year":"2007","unstructured":"Chen P, Hubner W, Spinelli MA, Chen BK: Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol. 2007, 81 (22): 12582-12595. 10.1128\/JVI.00381-07.","journal-title":"J Virol"},{"issue":"14","key":"3645_CR42","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1097\/QAD.0b013e3283632ec4","volume":"27","author":"CJ Duncan","year":"2013","unstructured":"Duncan CJ, Russell RA, Sattentau QJ: High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy. AIDS. 2013, 27 (14): 2201-2206. 10.1097\/QAD.0b013e3283632ec4.","journal-title":"AIDS"},{"issue":"3","key":"3645_CR43","doi-asserted-by":"publisher","first-page":"e1000345","DOI":"10.1371\/journal.ppat.1000345","volume":"5","author":"E Dam","year":"2009","unstructured":"Dam E, Quercia R, Glass B, Descamps D, Launay O, Duval X, Krausslich HG, Hance AJ, Clavel F, Group AS: Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss. PLoS Path. 2009, 5 (3): e1000345-10.1371\/journal.ppat.1000345.","journal-title":"PLoS Path"},{"issue":"10","key":"3645_CR44","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00894-010-0677-9","volume":"16","author":"P Dirauf","year":"2010","unstructured":"Dirauf P, Meiselbach H, Sticht H: Effects of the V82A and I54V mutations on the dynamics and ligand binding properties of HIV-1 protease. J Mol Mod. 2010, 16 (10): 1577-1583. 10.1007\/s00894-010-0677-9.","journal-title":"J Mol Mod"},{"issue":"3","key":"3645_CR45","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1128\/AAC.01228-10","volume":"55","author":"CM Parry","year":"2011","unstructured":"Parry CM, Kolli M, Myers RE, Cane PA, Schiffer C, Pillay D: Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacity. Antimicrob Agents Chemother. 2011, 55 (3): 1106-1113. 10.1128\/AAC.01228-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3645_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, et al: Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Eng J Med. 2012, 367 (5): 399-410. 10.1056\/NEJMoa1108524.","journal-title":"N Eng J Med"},{"issue":"8","key":"3645_CR47","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3851\/IMP2492","volume":"17","author":"C Celum","year":"2012","unstructured":"Celum C, Baeten JM: Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis. Antivir Ther. 2012, 17 (8): 1483-1493. 10.3851\/IMP2492.","journal-title":"Antivir Ther"},{"issue":"5","key":"3645_CR48","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi R, Onyango J, et al: Preexposure prophylaxis for HIV infection among African women. N Eng J Med. 2012, 367 (5): 411-422. 10.1056\/NEJMoa1202614.","journal-title":"N Eng J Med"},{"issue":"2","key":"3645_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1084\/jem.20030648","volume":"199","author":"C Jolly","year":"2004","unstructured":"Jolly C, Kashefi K, Hollinshead M, Sattentau QJ: HIV-1 cell to cell transfer across an env-induced, actin-dependent synapse. J Exp Med. 2004, 199 (2): 283-293. 10.1084\/jem.20030648.","journal-title":"J Exp Med"},{"issue":"9","key":"3645_CR50","doi-asserted-by":"publisher","first-page":"e1002226","DOI":"10.1371\/journal.ppat.1002226","volume":"7","author":"C Jolly","year":"2011","unstructured":"Jolly C, Welsch S, Michor S, Sattentau QJ: The regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapse. PLoS Path. 2011, 7 (9): e1002226-10.1371\/journal.ppat.1002226.","journal-title":"PLoS Path"},{"issue":"23","key":"3645_CR51","doi-asserted-by":"publisher","first-page":"9403","DOI":"10.1073\/pnas.0903107106","volume":"106","author":"JB Dinoso","year":"2009","unstructured":"Dinoso JB, Kim SY, Wiegand AM, Palmer SE, Gange SJ, Cranmer L, O\u2019Shea A, Callender M, Spivak A, Brennan T, et al: Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 2009, 106 (23): 9403-9408. 10.1073\/pnas.0903107106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3645_CR52","first-page":"590","volume":"55","author":"A Yilmaz","year":"2010","unstructured":"Yilmaz A, Verhofstede C, D\u2019Avolio A, Watson V, Hagberg L, Fuchs D, Svennerholm B, Gisslen M: Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy. J AIDS. 2010, 55 (5): 590-596.","journal-title":"J AIDS"},{"issue":"11","key":"3645_CR53","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/sj.mt.6300281","volume":"15","author":"L Apolonia","year":"2007","unstructured":"Apolonia L, Waddington SN, Fernandes C, Ward NJ, Bouma G, Blundell MP, Thrasher AJ, Collins MK, Philpott NJ: Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol Ther. 2007, 15 (11): 1947-1954. 10.1038\/sj.mt.6300281.","journal-title":"Mol Ther"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-10-161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T04:21:59Z","timestamp":1688876519000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-10-161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3645"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-10-161","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718216909.793491404","asserted-by":"object"}]},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"11 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"161"}}